Your browser doesn't support javascript.
loading
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.
Oliu-Barton, Miquel; Pradelski, Bary S R; Aghion, Philippe; Artus, Patrick; Kickbusch, Ilona; Lazarus, Jeffrey V; Sridhar, Devi; Vanderslott, Samantha.
Afiliação
  • Oliu-Barton M; Université Paris Dauphine-PSL, Paris, France; Esade Centre for Economic Policy, Barcelona, Spain.
  • Pradelski BSR; French National Centre of Scientific Research (CNRS), CS 40700, 38058 Grenoble cedex 9, France; Oxford-Man Institute of Quantitative Finance, University of Oxford, Oxford, UK. Electronic address: bary.pradelski@cnrs.fr.
  • Aghion P; Collège de France, Paris, France; London School of Economics and Political Science, London, UK; INSEAD, Fontainebleau, France.
  • Artus P; Natixis, Paris, France; Paris School of Economics, Paris, France.
  • Kickbusch I; Global Health Centre, Graduate Institute of International and Development Studies, Geneva, Switzerland.
  • Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Sridhar D; Global Health Governance Programme, Usher Institute of Population Health Sciences and Informatics and College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
  • Vanderslott S; Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, UK.
Lancet ; 397(10291): 2234-2236, 2021 06 12.
Article em En | MEDLINE | ID: mdl-33932328
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Controle de Doenças Transmissíveis / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Controle de Doenças Transmissíveis / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2021